Lantheus Holdings Inc
F:0L8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Lantheus Holdings Inc (0L8) under the Base Case is EUR per share.
Compared with the current market price of 90.3 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Lantheus Does
Lantheus Holdings makes diagnostic products that help doctors see disease inside the body, especially in cancer and heart imaging. Its main products are imaging agents used with PET, SPECT, ultrasound, and other scans, including the prostate cancer tracer PYLARIFY and the ultrasound contrast agent DEFINITY. These products do not treat patients directly; they help hospitals and imaging centers find and track disease more accurately.
- Headquarters
- United States of America US
- Employees
- 1 193
- IPO date
- Jun 25, 2015
Lantheus Holdings has a wide economic moat
Lantheus Holdings Inc possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Lantheus Holdings Inc
Earnings Waterfall
Lantheus Holdings Inc
What is the Intrinsic Value of one 0L8 stock?
The intrinsic value for Lantheus Holdings Inc (0L8) under the Base Case is EUR.
Is 0L8 stock undervalued or overvalued?
Compared with the current market price of 90.3 EUR, the stock appears .
